31 – 40 of 92
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Immunotherapy for Glioblastoma: The Devil Is in the Details Reply
- Contribution to journal › Letter
-
Mark
Challenges to the Development of New Agents for Molecularly Defined Patient Subsets: Lessons From BRCA1/2-Associated Breast Cancer
- Contribution to journal › Debate/Note/Editorial
-
Mark
Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008.
- Contribution to journal › Article
-
Mark
Population-Based Study of Treatment Guided by Tumor Marker Decline in Patients With Metastatic Nonseminomatous Germ Cell Tumor: A Report From the Swedish-Norwegian Testicular Cancer Group.
- Contribution to journal › Article
-
Mark
Digoxin use and the risk of breast cancer in women
- Contribution to journal › Article
-
Mark
Familial risks in cancer of unknown primary: tracking the primary sites.
- Contribution to journal › Article
-
Mark
Familial Mortality and Familial Incidence in Cancer.
- Contribution to journal › Article
-
Mark
Response-Guided Induction Therapy in Pediatric Acute Myeloid Leukemia With Excellent Remission Rate.
- Contribution to journal › Article
- 2010
-
Mark
Patterns of Improved Survival in Patients With Multiple Myeloma in the Twenty-First Century: A Population-Based Study.
- Contribution to journal › Article
-
Mark
Improving Surveillance and Quality of Life of BRCA Mutation Carriers.
- Contribution to journal › Article
